reported that prediction models combining serum ALT levels and relative abundance of encoding genes could discriminate participants in NAFLD, NASH, and severe fibrosis with AUCs of 0.95, 0,92, and 0.87, respectively(Schwimmer et al., 2019). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.